Recruiting

RecoveryPad

Sponsor:

Yale University

Code:

NCT07362082

Conditions

Opioid Use Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RecoveryPad platform

Study Details

Brief summary:

This trial will assess effects of enrollment in a comprehensive telehealth platform, RecoveryPad (RP), in adults with moderate or severe opioid use disorder.

Conditions

Opioid Use Disorder

Study ID

NCT07362082

Start date

Sep 11, 2026

Status verified date

Sep, 2026

Completion date

Dec 1, 2027

Anticipated

Primary completion date

Oct 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Can speak, read and write in English
  • Provision of signed and dated informed consent form
  • Screened positive for OUD, moderate or severe, based on the Diagnostic and Statistical Manual-5th Edition
  • Have a working cell phone number and working device that can access a web browser and receive texts (i.e., smartphone, tablet or computer)
  • Can provide a working email address OR be willing to create one

Exclusion Criteria:

  • Current use of buprenorphine, methadone, or naltrexone for a substance use disorder
  • Pregnancy
  • Known current suicide risk based on participant self-report
  • On parole or incarcerated at time of enrollment based on participant self-report

Study Design

Enrollment

470 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: RecoveryPad platform

Participants randomized to RecoveryPad platform

no intervention: Treatment as usual

Treatment as usual: referrals to harm reduction and other community resources that are already being given to individuals in the various community and healthcare settings from which these participants are being recruited.

Interventions

RecoveryPad platform

Telehealth platform to enhance motivation and engagement in treatment for OUD

Primary outcome measure

  • Attendance for MOUD [ Time Frame: Up to 30 days ]

Central Contacts and Locations

Central contacts

Rebekah Heckmann, MD

(203) 737-8335rebekah.heckmann@yale.edu

Locations

Yale University

Recruiting

New Haven, Connecticut, United States, 06520

More Information

Sponsor

Yale University

Last update posted

Sep 21, 2026

Last verified

Sep, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-24. This information was provided to ClinicalTrials.gov by Yale University on 2026-09-21. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.